Repare Therapeutics
IPO News: Repare Therapeutics File $100mm IPO
Repare Therapeutics

Repare Therapeutics Inc.

NASDAQ:  RPTX

Size:  $100mm

Bookrunners:  MS | GS | COWEN | PIPR

Major Holders:  Versant | MPM | Orbimed | UBS Oncology Impact Fund | Cowen

Description:  Repare is a precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics

 

Reference Link:  S-1